Higher in Transitional Terminators
|
5.2 |
BMPR1B |
Bone morphogenetic protein receptor, type IB |
8.6 |
4.79E-02 |
4.4 |
PTPN3 |
Protein tyrosine phosphatase, non-receptor type 3 |
11.5 |
3.92E-03 |
4.3 |
ATP8B4 |
ATPase phospholipid transporting 8B4 (putative) |
7.5 |
4.22E-03 |
4.2 |
FANK1 |
Fibronectin type III and ankyrin repeat domains 1 |
8.6 |
2.01E-02 |
4.2 |
BRCA1 |
Breast cancer 1, early onset |
7.3 |
2.86E-02 |
4.1 |
PTPN12 |
Protein tyrosine phosphatase, non-receptor type 12 |
7.4 |
1.77E-02 |
3.9 |
MTA3 |
Metastasis associated 1 family, member 3 |
10.1 |
9.33E-03 |
3.9 |
MPPED2 |
Metallophosphoesterase domain containing 2 |
7.0 |
2.80E-03 |
Higher in Transitional Carriers
|
−4.3 |
BNIP3L |
BCL2/adenovirus E1B 19 kDa interacting protein 3-like |
10.1 |
3.41E-02 |
−4.3 |
ATP10B |
ATPase phospholipid transporting 10B (putative) |
9.5 |
3.81E-02 |
−4.4 |
TBX3 |
T-box 3 |
8.2 |
2.10E-03 |
−4.6 |
CDKN2B-AS |
Cyclin dependent kinase inhibitor 2B, antisense |
10.5 |
4.79E-02 |
−4.6 |
SOX18 |
SRY (sex determining region Y)-box 18 |
9.1 |
1.44E-02 |
−4.8 |
HOXD9 |
Homeobox D9 |
6.2 |
1.56E-10 |
−5.0 |
CRABP1 |
Cellular retinoic acid binding protein 1 |
10.2 |
7.18E-04 |
−5.1 |
PPP1R16A |
Protein phosphatase 1, regulatory (inhibitor) subunit 16A |
10.2 |
1.01E-02 |
−5.1 |
NOV |
Nephroblastoma overexpressed gene |
10.7 |
6.47E-03 |
−5.2 |
MMP9 |
Matrix metalloproteinase 9 (type IV collagenase) |
9.8 |
1.81E-04 |